✦ LIBER ✦

Is there a scientific rationale for therapeutic plasma exchange or intravenous immune globulin in the treatment of acute guillain-barré syndrome?

✍ Scribed by Robert Weinstein

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 836 KB
Volume: 10
Category: Article
ISSN: 0733-2459
DOI: 10.1002/jca.2920100310

No coin nor oath required. For personal study only.

✦ Synopsis

IMMUNE MODULATION AND PLASMA EXCHANGE Transferable Serum Factors

In 1971, Stuart Cook and colleagues reported that sera from 26 of 31 patients with Guillain-Barre syndrome caused complement-dependent demyelination of living

📜 SIMILAR VOLUMES

Relapses in the Guillain–Barré syndrome

Relapses in the Guillain–Barré syndrome after treatment with intravenous immune globulin or plasma exchange

✍ J.G. Romano; F.T. Rotta; P. Potter; V. Rosenfeld; R. Santibanez; B. Rocha; W.G. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

To clarify the question of whether Guillain-Barre ´syndrome (GBS) patients treated with intravenous immune globulin (IVIG) relapse at a higher frequency than those treated with plasma exchange (PE), 54 patients with GBS were studied retrospectively. A higher frequency of relapses was noted in the PE